NCT00397540
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +25 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Clinical trial condition
Carcinoma, Hepatocellular
Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.
182 public trials
17 recruiting studies
Carcinoma, Hepatocellular trial results
NCT01306058
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Liver Cell, +13 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01258608
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Shreveport, Louisiana, United States
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site Tupelo, Mississippi, United States
NCT00243841
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Indiana University Department of Radiation Oncology Indianapolis, Indiana, United States
NCT02069041
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan City, Taiwan
Completed
Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
NCT00827723
- Conditions
- Adenocarcinoma, Alcohol-Induced Disorders, Alcohol-Related Disorders, +21 more
- Locations
-
- Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland
NCT01933945
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Multiple Locations, Austria
- Multiple Locations, Brazil
- Multiple Locations, Canada
- Multiple Locations, China
Completed
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
NCT00692770
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Los Angeles, California, United States
- Los Angeles, California, United States
NCT02848638
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
Not specified
NCT01490203
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cheonnam University Hwasun Hospital Hwasun-Gun, Cheonnam Province, South Korea
- Asan Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea
- The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, South Korea